glp-1 neuroinflammation The Impact of Receptor Agonists on Ocular Disease Activation of microglial GLP-1R in
Description
In STEP 1, patients with obesity (without diabetes) lost nearly 15% of body weight on weekly semaglutide
In theory, this could pave the way for even greater efficacy for GLP-1 treatments while also achieving an important reduction in the currently high rate of adverse GI events
If information is missing or patient is borderline, a nurse/pharmacist may manually review and either approve, deny, or ask for more details
From a clinical perspective, GLP-1s are generally safer with fewer abuse concerns, while phentermine has stimulant effects and contraindications in cardiovascular disease
Most participants tolerated the medication well by the end of the study period
For acute gastrointestinal losses, medically formulated oral rehydration salts (ORS) available from pharmacies are more appropriate than sports drinks
